/PRNewswire/ -- Compared to teens who have not seen their parent(s) drunk, those who have are more than twice as likely to get drunk in a typical month, and three times likelier to use marijuana and smoke cigarettes, according to the National Survey of American Attitudes on Substance Abuse XIV: Teens and Parents, the 14th annual back-to-school survey conducted by The National Center on Addiction and Substance Abuse (CASA) at Columbia University.
The CASA survey found that 51 percent of 17-year olds have seen one or both of their parents drunk and 34 percent of 12- to 17-year olds have seen one or both of their parents drunk.
Teen drinking behavior is strongly associated with how teens believe their fathers feel about their drinking. Compared to teens who believe their father is against their drinking, teens who believe their father is okay with their drinking are two and a half times likelier to get drunk in a typical month.
The survey found that five percent of 12- to 15-year old girls and nine percent of 12- to 15-year old boys say their fathers are okay with their drinking. Thirteen percent of 16- and 17-year old girls and 20 percent of 16- and 17-year old boys say their fathers are okay with their drinking.
"Some Moms' and Dads' behavior and attitudes make them parent enablers--parents who send their 12- to 17-year olds a message that it's okay to smoke, drink, get drunk and use illegal drugs like marijuana," said Joseph A. Califano, Jr., CASA's chairman and founder and former U.S. Secretary of Health, Education, and Welfare. "Teens' behavior is strongly associated with their parents' behavior and expectations, so parents who expect their children to drink and use drugs will have children who drink and use drugs."
Prescription Drugs Readily Available
For the first time this year, the survey asked 12- to 17-year olds how fast they can get prescription drugs to get high. More than one third of teens (8.7 million) can get prescription drugs to get high within a day; nearly one in five teens (4.7 million) can get them within an hour.
When teens were asked where they would get prescription drugs, the most common sources were home, parents, other family members and friends.
For the second year in a row more teens said prescription drugs were easier to buy than beer.
Drinking, Drugging and Sex
This year the CASA survey took a close look at teen drinking and discovered that 65 percent of 12- to 17-year olds who drink monthly report that they get drunk at least once in a typical month. Eighty-five percent of 17-year old drinkers get drunk at least once in a typical month.
The survey found that one third of teen drinkers usually drink with the intention to get drunk. Eighty-five percent of teen drinkers who say that when they drink they usually drink to get drunk do so at least once a month. Of those teens who do NOT set out to get drunk, 33 percent find themselves drunk at least once a month.
Compared to teens who have never tried alcohol, teens who get drunk monthly are:
-- 18 times likelier to have tried marijuana;
-- Four times likelier to be able to get marijuana in an hour;
-- Almost four times likelier to know someone their age who abuses
prescription drugs;
-- More than three times likelier to have friends who use marijuana; and
-- More than twice as likely to know someone their age who uses meth,
ecstasy, or other drugs such as cocaine, heroin or LSD.
Compared to teens who have never tried alcohol, those who get drunk at least once a month are:
-- Twice as likely to know a girl who was forced to do something sexual
she didn't want to do; and
-- Nearly four times likelier to know a guy who uses drugs or alcohol to
hook up.
"The message for parents is loud and clear. If your teen is drinking, the odds are your teen is getting drunk. And teens who get drunk are much likelier to try marijuana and hang out with friends who are abusing prescription drugs and illegal drugs like cocaine and heroin," said Elizabeth Planet, CASA's Vice President and Director of Special Projects. "Parents who think their kids are just having an occasional drink each month need to wake up and smell the beer and pot."
Marijuana, Availability Up Sharply
Between 2007 and 2009 there was a 37 percent increase in the percentage of 12- to 17-year olds who say marijuana is easier to buy than cigarettes, beer or prescription drugs (19 percent to 26 percent).
Forty percent of teens (10 million) can get marijuana within a day; nearly one-quarter of teens (5.7 million) can get it in an hour.
Teens who say that the decision to use marijuana by someone their age is not a big deal are four times more likely to use it compared to teens who say this decision is a big deal.
Teens whose parents believe the decision to use marijuana is not a big deal are almost twice as likely to use the drug, compared to teens whose parents say this decision is a big deal.
Most teens who smoke cigarettes (56 percent) say the decision to use marijuana is not a big deal.
Other Notable Findings
-- Two-thirds of high school students say that drugs are used, kept or
sold at their school.
-- Sixty percent of parents say that their child's school is not drug
free.
-- Of parents who say their teen's school is not drug free, almost half
think there is nothing they can do about it, and only a quarter have
even tried.
"Parents are the key to raising drug-free kids and they have the power to do it if they send their children the clear message to choose not to use and demand that the schools their children attend be drug free," noted Califano whose book How to Raise a Drug Free Kid: The Straight Dope for Parents, was published this month by Simon & Schuster's Touchstone/Fireside Division.
QEV Analytics conducted The National Survey of American Attitudes on Substance Abuse XIV: Teens and Parents from March 2 to April 5, 2009 (teens) and March 21 to April 10, 2009 (parents). The firm interviewed at home by telephone a national random sample of 1,000 12- to 17-year olds (509 boys, 491 girls) and 452 of their parents. Sampling error is +/- 3.1 percent for teens and +/- 4.6 percent for parents.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
Showing posts with label drugs. Show all posts
Showing posts with label drugs. Show all posts
Wednesday, August 26, 2009
Friday, January 09, 2009
FDA Awaits Court's Entry of A Permanent Injunction Against Actavis Totowa, LLC
Today, the U.S. Food and Drug Administration announced that it had filed a Consent Decree on December 23, 2008, and currently awaits the court's entry of a permanent injunction that bars Actavis Totowa, LLC, Actavis, Inc., and their officers, Sigurdur Oli Olafsson and Douglas Boothe, from manufacturing and distributing drugs at the Actavis Totowa facilities. The injunction will remain in effect until Actavis Totowa comes into compliance with U.S. current Good Manufacturing Practice (cGMP) requirements, and obtains FDA's approval to manufacture and distribute drugs in the United States. The companies and their officers had also been manufacturing and distributing unapproved drugs in the United States.
The defendants signed a consent decree that permits them to resume operations with respect to three categories of drugs only after an expert certifies that the drugs comply with the CGMP requirements and have FDA approval, and FDA inspects to confirm compliance with the law. The consent decree also requires defendants to destroy any remaining drugs that they recalled in April-July 2008, that are currently in their possession.
To view the complete list of unapproved drugs made by Actavis Totowa see List. The safety and effectiveness of these drugs has not been established because the company has not submitted for FDA review and approval new drug applications for them. FDA advises patients who have been using these products to discuss alternative therapies with their health care provider. Pharmacists should discontinue dispensing all unapproved drugs manufactured by Actavis Totowa.
"The FDA will not allow manufacturers to put the public's health at risk," said Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. "These unapproved new drugs have not undergone FDA review for safety and efficacy and may pose potential health risks."
The consent decree also authorizes FDA to order the defendants to cease operations in the event of future violations. It further subjects the defendants to liquidated damages of $15,000 per day if they fail to comply with any of the provisions of the decree, and to the payment of an additional $15,000 for each violation, up to $7 million per year.
Actavis Totowa manufactures, processes, packages, labels, holds, and distributes drugs from two sites in Totowa, N.J., and one in Little Falls, N.J. FDA inspected Actavis Totowa's Riverview Drive facility in Totowa from March-May 2008, and found that the company had significant cGMP violations and continued to manufacture unapproved drugs. As a result of this inspection, which led to this action, Actavis Totowa recalled all products manufactured and distributed from its three facilities. Actavis Totowa is a wholly owned subsidiary of Actavis, Inc., the manufacturing and marketing arm of Actavis Group hf, a generic pharmaceutical company based in Reykjavik, Iceland.
"The FDA will carefully monitor the provisions of this injunction to ensure compliance, said Michael Chappell, FDA acting associate commissioner, Office of Regulatory Affairs. "Companies should know that FDA will investigate and take action against other marketers of unapproved drugs."
The government's complaint, filed Nov. 14, 2008, by the U.S. Department of Justice in the District Court for the District of New Jersey, alleged that the defendants violated the Federal Food, Drug, and Cosmetic Act by not complying with cGMP requirements and failing to obtain FDA's approval of some of its drugs, two requirements designed to ensure the safety, effectiveness, and quality of pharmaceutical products.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
The defendants signed a consent decree that permits them to resume operations with respect to three categories of drugs only after an expert certifies that the drugs comply with the CGMP requirements and have FDA approval, and FDA inspects to confirm compliance with the law. The consent decree also requires defendants to destroy any remaining drugs that they recalled in April-July 2008, that are currently in their possession.
To view the complete list of unapproved drugs made by Actavis Totowa see List. The safety and effectiveness of these drugs has not been established because the company has not submitted for FDA review and approval new drug applications for them. FDA advises patients who have been using these products to discuss alternative therapies with their health care provider. Pharmacists should discontinue dispensing all unapproved drugs manufactured by Actavis Totowa.
"The FDA will not allow manufacturers to put the public's health at risk," said Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. "These unapproved new drugs have not undergone FDA review for safety and efficacy and may pose potential health risks."
The consent decree also authorizes FDA to order the defendants to cease operations in the event of future violations. It further subjects the defendants to liquidated damages of $15,000 per day if they fail to comply with any of the provisions of the decree, and to the payment of an additional $15,000 for each violation, up to $7 million per year.
Actavis Totowa manufactures, processes, packages, labels, holds, and distributes drugs from two sites in Totowa, N.J., and one in Little Falls, N.J. FDA inspected Actavis Totowa's Riverview Drive facility in Totowa from March-May 2008, and found that the company had significant cGMP violations and continued to manufacture unapproved drugs. As a result of this inspection, which led to this action, Actavis Totowa recalled all products manufactured and distributed from its three facilities. Actavis Totowa is a wholly owned subsidiary of Actavis, Inc., the manufacturing and marketing arm of Actavis Group hf, a generic pharmaceutical company based in Reykjavik, Iceland.
"The FDA will carefully monitor the provisions of this injunction to ensure compliance, said Michael Chappell, FDA acting associate commissioner, Office of Regulatory Affairs. "Companies should know that FDA will investigate and take action against other marketers of unapproved drugs."
The government's complaint, filed Nov. 14, 2008, by the U.S. Department of Justice in the District Court for the District of New Jersey, alleged that the defendants violated the Federal Food, Drug, and Cosmetic Act by not complying with cGMP requirements and failing to obtain FDA's approval of some of its drugs, two requirements designed to ensure the safety, effectiveness, and quality of pharmaceutical products.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
Saturday, January 03, 2009
FDA Prevents Two Dairies from Adulterating Animal Drugs and Food
The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in Clovis, N.M.
FDA has cited the defendants on multiple occasions, most recently following inspections of the dairies from June 24 to July 1, 2008. During these inspections the FDA investigator noted that the defendants were not keeping adequate medication records to prevent unsafe drug residues in cattle offered for slaughter, that they failed to review treatment records prior to offering an animal for slaughter, and that they were using medications for unapproved indications not specified on the drug label. Although using drugs in this "extralabel" manner is legal with a valid veterinarian-client-patient relationship, the defendants did not have such a relationship.
FDA previously inspected Do-Rene Dairy on Feb. 1-5, 2005, and subsequently sent the owners a Warning Letter summarizing the deviations, which were similar to those found in the 2008 inspection. The letter informed the owners that a failure to correct all violations may result in enforcement action, including seizure or injunction.
In tissue samples collected since 2003, FDA determined that Do-Rene and Clover Knolls Dairies offered 12 animals for slaughter with illegal drug residues. The animals included dairy cows that tested positive for illegal levels of the drugs flunixin, penicillin, neomycin and sulfadimethoxine, a drug expressly forbidden for use in lactating cows. In addition, four bob veal calves tested positive for sulfamethoxazole. (Bob veal calves are calves less than 30 days old and may be as young as two days at slaughter.) These residues may cause allergic reactions in extremely sensitive individuals, and they may contribute to forming antibiotic-resistance in bacteria.
Under the terms of the consent decree, the defendants and their employees cannot introduce any adulterated food into commerce, use animal drugs in an "extralabel" manner without a valid veterinarian-client-patient relationship, or use drugs in animals in which such drugs are expressly forbidden. Failure to obey the terms of the consent decree could result in civil or criminal penalties.
-----
www.fayettefrontpage.com
Fayette Front Page
Community News You Can Use
Fayetteville, Peachtree City, Tyrone
www.georgiafrontpage.com
Georgia Front Page
FDA has cited the defendants on multiple occasions, most recently following inspections of the dairies from June 24 to July 1, 2008. During these inspections the FDA investigator noted that the defendants were not keeping adequate medication records to prevent unsafe drug residues in cattle offered for slaughter, that they failed to review treatment records prior to offering an animal for slaughter, and that they were using medications for unapproved indications not specified on the drug label. Although using drugs in this "extralabel" manner is legal with a valid veterinarian-client-patient relationship, the defendants did not have such a relationship.
FDA previously inspected Do-Rene Dairy on Feb. 1-5, 2005, and subsequently sent the owners a Warning Letter summarizing the deviations, which were similar to those found in the 2008 inspection. The letter informed the owners that a failure to correct all violations may result in enforcement action, including seizure or injunction.
In tissue samples collected since 2003, FDA determined that Do-Rene and Clover Knolls Dairies offered 12 animals for slaughter with illegal drug residues. The animals included dairy cows that tested positive for illegal levels of the drugs flunixin, penicillin, neomycin and sulfadimethoxine, a drug expressly forbidden for use in lactating cows. In addition, four bob veal calves tested positive for sulfamethoxazole. (Bob veal calves are calves less than 30 days old and may be as young as two days at slaughter.) These residues may cause allergic reactions in extremely sensitive individuals, and they may contribute to forming antibiotic-resistance in bacteria.
Under the terms of the consent decree, the defendants and their employees cannot introduce any adulterated food into commerce, use animal drugs in an "extralabel" manner without a valid veterinarian-client-patient relationship, or use drugs in animals in which such drugs are expressly forbidden. Failure to obey the terms of the consent decree could result in civil or criminal penalties.
-----
www.fayettefrontpage.com
Fayette Front Page
Community News You Can Use
Fayetteville, Peachtree City, Tyrone
www.georgiafrontpage.com
Georgia Front Page
Monday, June 23, 2008
Coming Soon: Generic Drugs from China
TT Note: Say it ain't so. Yet again, China appears to be on the brink of exporting more into the country and this time, it's something that could really hurt or kill us. With all the safety issues with all of the recalls, do you want to trust they will make drugs safe? Here's the full story from Consumer Affairs.
If you liked the heparin, dog food, lead-painted toys, toothpaste and truck tires from China, you'll be happy to hear that Chinese-made generic drugs are making their way to the U.S. While the development raises some safety concerns....
Read the story.
If you liked the heparin, dog food, lead-painted toys, toothpaste and truck tires from China, you'll be happy to hear that Chinese-made generic drugs are making their way to the U.S. While the development raises some safety concerns....
Read the story.
Sunday, December 30, 2007
Violent Border Smugglers Scare U.S. Scientists
Reading a title about violent border smugglers, the first thing I'd think was there were problems in any part of the world but the United States. But no, this article is about our southern border with Mexico. It's hard to imagine trucks full of gun-toting smugglers coming easily across our borders. Reading the article below brought home the seriousness of the problem in ways that none of the other articles I've read have done thus far.
We have a huge problem. Our politicians seem to be making token attempts to placate those who raise a fuss about illegal aliens, drug smuggling and the potential for terrorists to walk across our border. The louder the up swell of our discontent the more token bandaids they plaster. The problem is we don't need bandaids, we need serious surgery along with heavy antibiotics.
I understand it's another one of those huge, complicated problems that could have been solved easily years back. Now it's grown to be such a monster that any solution is going to hurt someone somewhere. Somehow we've got to figure out a way for the business faction, the various political factions and any other factions involved to see the big picture.
Violent Border Smugglers Scare U.S. Scientists
Fox News / PHOENIX — Biologist Karen Krebbs used to study bats in Organ Pipe Cactus National Monument on the Arizona-Mexico border. Then, she got tired of dodging drug smugglers all night.
"I use night-vision goggles, and you could see them very clearly" — caravans of men with guns and huge backpacks full of drugs, trudging through the desert, Krebbs said. After her 10th or 11th time hiding in bushes and behind rocks, she abandoned her research.
http://www.foxnews.com/story/0,2933,319028,00.html
We have a huge problem. Our politicians seem to be making token attempts to placate those who raise a fuss about illegal aliens, drug smuggling and the potential for terrorists to walk across our border. The louder the up swell of our discontent the more token bandaids they plaster. The problem is we don't need bandaids, we need serious surgery along with heavy antibiotics.
I understand it's another one of those huge, complicated problems that could have been solved easily years back. Now it's grown to be such a monster that any solution is going to hurt someone somewhere. Somehow we've got to figure out a way for the business faction, the various political factions and any other factions involved to see the big picture.
Violent Border Smugglers Scare U.S. Scientists
Fox News / PHOENIX — Biologist Karen Krebbs used to study bats in Organ Pipe Cactus National Monument on the Arizona-Mexico border. Then, she got tired of dodging drug smugglers all night.
"I use night-vision goggles, and you could see them very clearly" — caravans of men with guns and huge backpacks full of drugs, trudging through the desert, Krebbs said. After her 10th or 11th time hiding in bushes and behind rocks, she abandoned her research.
http://www.foxnews.com/story/0,2933,319028,00.html
Subscribe to:
Posts (Atom)
